NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
ENVOYER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/06/2026
Trademark type
Word
Nice classes
5, 42
Filing date
01/25/2024
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/20/2024
First use in commerce
08/20/2024
Drawing code
4
Owner type
03
Owner location
Brookline, MA
Examiner
KEATING, MICHAEL P
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Envoya Inc.
Representatives
Susan G. L. Glovsky Hamilton, Brook, Smith & Reynolds, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Gene therapy productsnon-lipid polymer based nanoparticles for gene therapy; gene therapy productsnamely polymer-based nanoparticles for medicalveterinary and pharmaceutical purposes; nucleic acid-containing productsnamely RNA and DNAfor medical or veterinary purposes; gene therapy products for the treatment of cancermetabolic diseases or disordersneurodegenerative diseases or disorderscardiovascular diseases or disordersinfectious diseasesinflammatory diseases or disordersnon-viral vectors; nanoparticle products for medical or veterinary purposesnon-viral vectors; nanoparticles for medical or veterinary purposesstabilized non-lipid polymer based nanoparticles; nanoparticles that encapsulate nucleic acids for medical or veterinary purposes; nanoparticles that encapsulate cytotoxic payloads in cells for medical or veterinary purposes
Class 42
Pharmaceutical research and development; research and development services in the field of pharmaceuticals; gene therapy research and development services; research and development services relating to the delivery of RNA and DNA therapeutics to patients; research and development services in the field of nanoparticles and microparticles; research and development services in the field of nucleic acid-containing particles; research and development services in the field of nucleic acidsproteinssmall molecules delivery; Development of nucleic acidsnamely RNA and DNAfor encapsulating nanoparticles for targeted delivery; Research services in the field of nanoparticle characteristics; Research services in the field of microparticle characteristics; research and development services in the field of pharmaceutical preparations for the treatment of disease or disorders; research and development services in the field of pharmaceutical preparations for the treatment of cancermuscular dystrophymetabolic diseases or disordersneurodegenerative diseases or disorderscardiovascular diseases or disordersinfectious diseasesinflammatory diseases or disordersrare diseases; scientific and technological servicesscientific researchanalysistestingtreatment optimizations in the field of nucleic acidsproteinssmall molecules delivery to human cells; scientific and technological servicesscientific researchanalysistestingtreatment optimizations in the field of protein delivery to human cells; Scientific and technological servicesresearch and design relating to scientific and technological services in the field of nucleic acidsproteinssmall molecules therapeutics
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/15/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/15/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/10/2025
EX1G
SOU EXTENSION 1 GRANTED
12/10/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/10/2025
DOCK
ASSIGNED TO EXAMINER
08/25/2025
EXT1
SOU EXTENSION 1 FILED
06/24/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/24/2025
IUAF
USE AMENDMENT FILED
04/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/15/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/28/2024
GNRT
NON-FINAL ACTION E-MAILED
08/28/2024
CNRT
NON-FINAL ACTION WRITTEN
08/28/2024
DOCK
ASSIGNED TO EXAMINER
08/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2024
NWAP
NEW APPLICATION ENTERED
01/25/2024
Continuous trademark protection
Get notified about every new filing that threatens ENVOYER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.